{"count": 21, "results": [{"_id": "35277075", "pmid": 35277075, "pmcid": "PMC8838100", "title": "Simvastatin Improves Microcirculatory Function in Nonalcoholic Fatty Liver Disease and Downregulates Oxidative and ALE-RAGE Stress", "journal": "Nutrients", "authors": ["Pereira ENGDS", "Araujo BP", "Rodrigues KL", "Silvares RR", "Martins CSM", "Flores EEI", "Fernandes-Santos C", "Daliry A"], "date": "2022-02-08T00:00:00Z", "doi": "10.3390/nu14030716", "meta_date_publication": "2022 Feb 8", "meta_volume": "14", "meta_issue": "3", "meta_pages": "", "score": 50270.297, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ Improves Microcirculatory Function in @<m>DISEASE_Non_alcoholic_Fatty_Liver_Disease</m> @DISEASE_MESH:D065626 @@@Nonalcoholic Fatty Liver Disease@@@ and Downregulates Oxidative and ALE-@GENE_AGER @GENE_177 @@@RAGE@@@ Stress", "citations": {"NLM": "Pereira ENGDS, Araujo BP, Rodrigues KL, Silvares RR, Martins CSM, Flores EEI, Fernandes-Santos C, Daliry A. Simvastatin Improves Microcirculatory Function in Nonalcoholic Fatty Liver Disease and Downregulates Oxidative and ALE-RAGE Stress Nutrients. 2022 Feb 8;14(3):. PMID: 35277075", "BibTeX": "@article{35277075, title={Simvastatin Improves Microcirculatory Function in Nonalcoholic Fatty Liver Disease and Downregulates Oxidative and ALE-RAGE Stress}, author={Pereira ENGDS and Araujo BP and Rodrigues KL and Silvares RR and Martins CSM and Flores EEI and Fernandes-Santos C and Daliry A}, journal={Nutrients}, volume={14}, number={3}}"}}, {"_id": "36520527", "pmid": 36520527, "title": "Effects of metformin and simvastatin treatment on ultrastructural features of liver macrophages in HFD mice.", "journal": "Ultrastruct Pathol", "authors": ["Ciric D", "Kravic-Stevovic T", "Bumbasirevic V", "Petricevic S", "Jovanovic S", "Trajkovic V", "Martinovic T"], "date": "2023-01-02T00:00:00Z", "doi": "10.1080/01913123.2022.2156639", "meta_date_publication": "2023 Jan 2", "meta_volume": "47", "meta_issue": "1", "meta_pages": "1-11", "score": 50254.625, "text_hl": "Both @CHEMICAL_Metformin @CHEMICAL_MESH:D008687 @@@metformin@@@ and @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ reduced the @DISEASE_Chemical_and_Drug_Induced_Liver_Injury @DISEASE_MESH:D056486 @@@liver damage@@@ in HFD fed animals, manifested as the prevention of @<m>DISEASE_Non_alcoholic_Fatty_Liver_Disease</m> @DISEASE_MESH:D065626 @@@nonalcoholic steatohepatitis@@@ development and reduced activation and number of macrophages in the liver, as well as the percentage of these cells with @CHEMICAL_Lipids @CHEMICAL_MESH:D008055 @@@lipid@@@ droplets in the cytoplasm compared to untreated HFD animals. ", "citations": {"NLM": "Ciric D, Kravic-Stevovic T, Bumbasirevic V, Petricevic S, Jovanovic S, Trajkovic V, Martinovic T. Effects of metformin and simvastatin treatment on ultrastructural features of liver macrophages in HFD mice. Ultrastruct Pathol. 2023 Jan 2;47(1):1-11. PMID: 36520527", "BibTeX": "@article{36520527, title={Effects of metformin and simvastatin treatment on ultrastructural features of liver macrophages in HFD mice.}, author={Ciric D and Kravic-Stevovic T and Bumbasirevic V and Petricevic S and Jovanovic S and Trajkovic V and Martinovic T}, journal={Ultrastruct Pathol}, volume={47}, number={1}, pages={1-11}}"}}, {"_id": "37644746", "pmid": 37644746, "title": "Statins as a Potential Treatment for Non-Alcoholic Fatty Liver Disease: Target Deconvolution using Protein-protein Interaction Network Analysis.", "journal": "Curr Med Chem", "authors": ["Mahmoudi A", "Butler AE", "Orekhov AN", "Jamialahmadi T", "Sahebkar A"], "date": "2023-08-29T00:00:00Z", "doi": "10.2174/0929867331666230829164832", "meta_date_publication": "2023 Aug 29", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50251.453, "text_hl": "CONCLUSIONS: @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ has the most impact on @<m>DISEASE_Non_alcoholic_Fatty_Liver_Disease</m> @DISEASE_MESH:D065626 @@@NAFLD@@@-related genes versus other statins.", "citations": {"NLM": "Mahmoudi A, Butler AE, Orekhov AN, Jamialahmadi T, Sahebkar A. Statins as a Potential Treatment for Non-Alcoholic Fatty Liver Disease: Target Deconvolution using Protein-protein Interaction Network Analysis. Curr Med Chem. 2023 Aug 29;():. PMID: 37644746", "BibTeX": "@article{37644746, title={Statins as a Potential Treatment for Non-Alcoholic Fatty Liver Disease: Target Deconvolution using Protein-protein Interaction Network Analysis.}, author={Mahmoudi A and Butler AE and Orekhov AN and Jamialahmadi T and Sahebkar A}, journal={Curr Med Chem}}"}}, {"_id": "32145332", "pmid": 32145332, "title": "Promising therapeutic use of Baccharis trimera (less.) DC. as a natural hepatoprotective agent against hepatic lesions that are caused by multiple risk factors.", "journal": "J Ethnopharmacol", "authors": ["Barbosa RJ", "Ratti da Silva G", "Cola IM", "Kuchler JC", "Coelho N", "Barboza LN", "Menetrier JV", "de Souza R", "Zonta FN", "Froehlich DL", "Jacomassi E", "Soares AA", "Velasques LG", "Veiga AA", "Souza LM", "Lovato ECW", "Ribeiro-Paes JT", "Gasparotto Junior A", "Acco A", "Lívero FADR"], "date": "2020-05-23T00:00:00Z", "doi": "10.1016/j.jep.2020.112729", "meta_date_publication": "2020 May 23", "meta_volume": "254", "meta_issue": "", "meta_pages": "112729", "score": 50248.36, "text_hl": "In contrast to insulin + @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ treatment, all three doses of B. trimera effectively reduced @GENE_GOT2 @GENE_25721 @@@AST@@@ and ALT levels. ", "citations": {"NLM": "Barbosa RJ, Ratti da Silva G, Cola IM, Kuchler JC, Coelho N, Barboza LN, Menetrier JV, de Souza R, Zonta FN, Froehlich DL, Jacomassi E, Soares AA, Velasques LG, Veiga AA, Souza LM, Lovato ECW, Ribeiro-Paes JT, Gasparotto Junior A, Acco A, Lívero FADR. Promising therapeutic use of Baccharis trimera (less.) DC. as a natural hepatoprotective agent against hepatic lesions that are caused by multiple risk factors. J Ethnopharmacol. 2020 May 23;254():112729. PMID: 32145332", "BibTeX": "@article{32145332, title={Promising therapeutic use of Baccharis trimera (less.) DC. as a natural hepatoprotective agent against hepatic lesions that are caused by multiple risk factors.}, author={Barbosa RJ and Ratti da Silva G and Cola IM and Kuchler JC and Coelho N and Barboza LN and Menetrier JV and de Souza R and Zonta FN and Froehlich DL and Jacomassi E and Soares AA and Velasques LG and Veiga AA and Souza LM and Lovato ECW and Ribeiro-Paes JT and Gasparotto Junior A and Acco A and Lívero FADR}, journal={J Ethnopharmacol}, volume={254}, pages={112729}}"}}, {"_id": "32242391", "pmid": 32242391, "title": "Sini powder ameliorates the inflammatory response in rats with stress-induced non-alcoholic fatty liver disease by inhibiting the nuclear factor kappa-B / pyrin domain-containing protein 3 pathway.", "journal": "J Tradit Chin Med", "authors": ["Mu J", "Cheng F", "Wang Q", "Wang X", "Zhu W", "Ma C", "Yin X", "Ren B", "Lian Y", "Du X", "Zhang H", "Liu S", "Zhang S"], "date": "2020-04-01T00:00:00Z", "meta_date_publication": "2020 Apr", "meta_volume": "40", "meta_issue": "2", "meta_pages": "253-266", "score": 50246.457, "text_hl": "Both @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ and Sini powder significantly ameliorated the @<m>DISEASE_Non_alcoholic_Fatty_Liver_Disease</m> @DISEASE_MESH:D065626 @@@NAFLD@@@ pathology and the abnormal expression of NF-kappaB, @GENE_NLRP3 @GENE_287362 @@@NLRP3@@@, @GENE_PYCARD @GENE_282817 @@@ASC@@@, @GENE_CASP1 @GENE_25166 @@@caspase-1@@@, @GENE_IL1B @GENE_24494 @@@IL-1beta@@@, and @GENE_IL6 @GENE_24498 @@@IL-6@@@ (all P < 0.01). ", "citations": {"NLM": "Mu J, Cheng F, Wang Q, Wang X, Zhu W, Ma C, Yin X, Ren B, Lian Y, Du X, Zhang H, Liu S, Zhang S. Sini powder ameliorates the inflammatory response in rats with stress-induced non-alcoholic fatty liver disease by inhibiting the nuclear factor kappa-B / pyrin domain-containing protein 3 pathway. J Tradit Chin Med. 2020 Apr;40(2):253-266. PMID: 32242391", "BibTeX": "@article{32242391, title={Sini powder ameliorates the inflammatory response in rats with stress-induced non-alcoholic fatty liver disease by inhibiting the nuclear factor kappa-B / pyrin domain-containing protein 3 pathway.}, author={Mu J and Cheng F and Wang Q and Wang X and Zhu W and Ma C and Yin X and Ren B and Lian Y and Du X and Zhang H and Liu S and Zhang S}, journal={J Tradit Chin Med}, volume={40}, number={2}, pages={253-266}}"}}, {"_id": "30047465", "pmid": 30047465, "title": "Ilexgenin A enhances the effects of simvastatin on non-alcoholic fatty liver disease without changes in simvastatin pharmacokinetics.", "journal": "Chin J Nat Med", "authors": ["Lu YW", "Zhu YC", "Zhang L", "Li P", "Yang J", "Wen XD"], "date": "2018-06-01T00:00:00Z", "doi": "10.1016/S1875-5364(18)30077-3", "meta_date_publication": "2018 Jun", "meta_volume": "16", "meta_issue": "6", "meta_pages": "436-445", "score": 50073.85, "text_hl": "@CHEMICAL_ilexgenin_A @CHEMICAL_MESH:C468850 @@@Ilexgenin A@@@ enhances the effects of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ on @<m>DISEASE_Non_alcoholic_Fatty_Liver_Disease</m> @DISEASE_MESH:D065626 @@@non-alcoholic fatty liver disease@@@ without changes in @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ pharmacokinetics.", "citations": {"NLM": "Lu YW, Zhu YC, Zhang L, Li P, Yang J, Wen XD. Ilexgenin A enhances the effects of simvastatin on non-alcoholic fatty liver disease without changes in simvastatin pharmacokinetics. Chin J Nat Med. 2018 Jun;16(6):436-445. PMID: 30047465", "BibTeX": "@article{30047465, title={Ilexgenin A enhances the effects of simvastatin on non-alcoholic fatty liver disease without changes in simvastatin pharmacokinetics.}, author={Lu YW and Zhu YC and Zhang L and Li P and Yang J and Wen XD}, journal={Chin J Nat Med}, volume={16}, number={6}, pages={436-445}}"}}, {"_id": "19448566", "pmid": 19448566, "title": "A pilot study using simvastatin in the treatment of nonalcoholic steatohepatitis: A randomized placebo-controlled trial.", "journal": "J Clin Gastroenterol", "authors": ["Nelson A", "Torres DM", "Morgan AE", "Fincke C", "Harrison SA"], "date": "2009-11-01T00:00:00Z", "doi": "10.1097/MCG.0b013e31819c392e", "meta_date_publication": "2009 Nov-Dec", "meta_volume": "43", "meta_issue": "10", "meta_pages": "990-4", "score": 50069.94, "text_hl": "A pilot study using @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ in the treatment of @<m>DISEASE_Non_alcoholic_Fatty_Liver_Disease</m> @DISEASE_MESH:D065626 @@@nonalcoholic steatohepatitis@@@: A randomized placebo-controlled trial.", "citations": {"NLM": "Nelson A, Torres DM, Morgan AE, Fincke C, Harrison SA. A pilot study using simvastatin in the treatment of nonalcoholic steatohepatitis: A randomized placebo-controlled trial. J Clin Gastroenterol. 2009 Nov-Dec;43(10):990-4. PMID: 19448566", "BibTeX": "@article{19448566, title={A pilot study using simvastatin in the treatment of nonalcoholic steatohepatitis: A randomized placebo-controlled trial.}, author={Nelson A and Torres DM and Morgan AE and Fincke C and Harrison SA}, journal={J Clin Gastroenterol}, volume={43}, number={10}, pages={990-4}}"}}, {"_id": "19946244", "pmid": 19946244, "title": "Safety and efficacy of combined ezetimibe/simvastatin treatment and simvastatin monotherapy in patients with non-alcoholic fatty liver disease.", "journal": "Med Sci Monit", "authors": ["Abel T", "Fehér J", "Dinya E", "Eldin MG", "Kovács A"], "date": "2009-12-01T00:00:00Z", "meta_date_publication": "2009 Dec", "meta_volume": "15", "meta_issue": "12", "meta_pages": "MS6-11", "score": 50069.09, "text_hl": "Safety and efficacy of combined @CHEMICAL_Ezetimibe @CHEMICAL_MESH:D000069438 @@@ezetimibe@@@/@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ treatment and @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ monotherapy in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Non_alcoholic_Fatty_Liver_Disease</m> @DISEASE_MESH:D065626 @@@non-alcoholic fatty liver disease@@@.", "citations": {"NLM": "Abel T, Fehér J, Dinya E, Eldin MG, Kovács A. Safety and efficacy of combined ezetimibe/simvastatin treatment and simvastatin monotherapy in patients with non-alcoholic fatty liver disease. Med Sci Monit. 2009 Dec;15(12):MS6-11. PMID: 19946244", "BibTeX": "@article{19946244, title={Safety and efficacy of combined ezetimibe/simvastatin treatment and simvastatin monotherapy in patients with non-alcoholic fatty liver disease.}, author={Abel T and Fehér J and Dinya E and Eldin MG and Kovács A}, journal={Med Sci Monit}, volume={15}, number={12}, pages={MS6-11}}"}}, {"_id": "27634010", "pmid": 27634010, "title": "Statins improve NASH via inhibition of RhoA and Ras.", "journal": "Am J Physiol Gastrointest Liver Physiol", "authors": ["Schierwagen R", "Maybüchen L", "Hittatiya K", "Klein S", "Uschner FE", "Braga TT", "Franklin BS", "Nickenig G", "Strassburg CP", "Plat J", "Sauerbruch T", "Latz E", "Lütjohann D", "Zimmer S", "Trebicka J"], "date": "2016-10-01T00:00:00Z", "doi": "10.1152/ajpgi.00063.2016", "meta_date_publication": "2016 Oct 1", "meta_volume": "311", "meta_issue": "4", "meta_pages": "G724-G733", "score": 50066.02, "text_hl": "Statins improve @<m>DISEASE_Non_alcoholic_Fatty_Liver_Disease</m> @DISEASE_MESH:D065626 @@@NASH@@@ via inhibition of @GENE_RHOA @GENE_11848 @@@RhoA@@@ and Ras.", "citations": {"NLM": "Schierwagen R, Maybüchen L, Hittatiya K, Klein S, Uschner FE, Braga TT, Franklin BS, Nickenig G, Strassburg CP, Plat J, Sauerbruch T, Latz E, Lütjohann D, Zimmer S, Trebicka J. Statins improve NASH via inhibition of RhoA and Ras. Am J Physiol Gastrointest Liver Physiol. 2016 Oct 1;311(4):G724-G733. PMID: 27634010", "BibTeX": "@article{27634010, title={Statins improve NASH via inhibition of RhoA and Ras.}, author={Schierwagen R and Maybüchen L and Hittatiya K and Klein S and Uschner FE and Braga TT and Franklin BS and Nickenig G and Strassburg CP and Plat J and Sauerbruch T and Latz E and Lütjohann D and Zimmer S and Trebicka J}, journal={Am J Physiol Gastrointest Liver Physiol}, volume={311}, number={4}, pages={G724-G733}}"}}, {"_id": "31316716", "pmid": 31316716, "pmcid": "PMC6604429", "title": "Simvastatin Reduces Hepatic Oxidative Stress and Endoplasmic Reticulum Stress in Nonalcoholic Steatohepatitis Experimental Model", "journal": "Oxid Med Cell Longev", "authors": ["Rodrigues G", "Moreira AJ", "Bona S", "Schemitt E", "Marroni CA", "Di Naso FC", "Dias AS", "Pires TR", "Picada JN", "Marroni NP"], "date": "2019-06-18T00:00:00Z", "doi": "10.1155/2019/3201873", "meta_date_publication": "2019", "meta_volume": "2019", "meta_issue": "", "meta_pages": "3201873", "score": 50065.99, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ Reduces Hepatic Oxidative Stress and Endoplasmic Reticulum Stress in @<m>DISEASE_Non_alcoholic_Fatty_Liver_Disease</m> @DISEASE_MESH:D065626 @@@Nonalcoholic Steatohepatitis@@@ Experimental Model", "citations": {"NLM": "Rodrigues G, Moreira AJ, Bona S, Schemitt E, Marroni CA, Di Naso FC, Dias AS, Pires TR, Picada JN, Marroni NP. Simvastatin Reduces Hepatic Oxidative Stress and Endoplasmic Reticulum Stress in Nonalcoholic Steatohepatitis Experimental Model Oxid Med Cell Longev. 2019;2019():3201873. PMID: 31316716", "BibTeX": "@article{31316716, title={Simvastatin Reduces Hepatic Oxidative Stress and Endoplasmic Reticulum Stress in Nonalcoholic Steatohepatitis Experimental Model}, author={Rodrigues G and Moreira AJ and Bona S and Schemitt E and Marroni CA and Di Naso FC and Dias AS and Pires TR and Picada JN and Marroni NP}, journal={Oxid Med Cell Longev}, volume={2019}, pages={3201873}}"}}]}